105 related articles for article (PubMed ID: 15078217)
1. New highly potent and selective adenosine A(3) receptor antagonists.
Press NJ; Keller TH; Tranter P; Beer D; Jones K; Faessler A; Heng R; Lewis C; Howe T; Gedeck P; Mazzoni L; Fozard JR
Curr Top Med Chem; 2004; 4(8):863-70. PubMed ID: 15078217
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of thiazole and thiadiazole derivatives as potent and selective human adenosine A3 receptor antagonists.
Jung KY; Kim SK; Gao ZG; Gross AS; Melman N; Jacobson KA; Kim YC
Bioorg Med Chem; 2004 Feb; 12(3):613-23. PubMed ID: 14738972
[TBL] [Abstract][Full Text] [Related]
3. Selective and potent adenosine A3 receptor antagonists by methoxyaryl substitution on the N-(2,6-diarylpyrimidin-4-yl)acetamide scaffold.
Yaziji V; Rodríguez D; Coelho A; García-Mera X; El Maatougui A; Brea J; Loza MI; Cadavid MI; Gutiérrez-de-Terán H; Sotelo E
Eur J Med Chem; 2013 Jan; 59():235-42. PubMed ID: 23231967
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of 2-(benzothiazolylthio)acetamide class of CCR3 selective antagonist.
Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
Chem Pharm Bull (Tokyo); 2003 Jun; 51(6):697-701. PubMed ID: 12808249
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.
Hong YR; Kim HT; Ro S; Cho JM; Lee SH; Kim IS; Jung YH
Bioorg Med Chem Lett; 2014 Jul; 24(14):3142-5. PubMed ID: 24894560
[TBL] [Abstract][Full Text] [Related]
6. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
[TBL] [Abstract][Full Text] [Related]
7. Effect of Nitrogen Atom Substitution in A
Azuaje J; Jespers W; Yaziji V; Mallo A; Majellaro M; Caamaño O; Loza MI; Cadavid MI; Brea J; Åqvist J; Sotelo E; Gutiérrez-de-Terán H
J Med Chem; 2017 Sep; 60(17):7502-7511. PubMed ID: 28792759
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of 4-phenyl-5-pyridyl-1,3-thiazole derivatives as selective adenosine A3 antagonists.
Miwatashi S; Arikawa Y; Matsumoto T; Uga K; Kanzaki N; Imai YN; Ohkawa S
Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1126-37. PubMed ID: 18670113
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic activity of some novel N-pyridinyl-2-(6-phenylimidazo[2,1-b]thiazol-3-yl)acetamide derivatives.
Ding H; Chen Z; Zhang C; Xin T; Wang Y; Song H; Jiang Y; Chen Y; Xu Y; Tan C
Molecules; 2012 Apr; 17(4):4703-16. PubMed ID: 22525437
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and electrophysiological characterization of almorexant, a dual orexin 1 receptor (OX1)/orexin 2 receptor (OX2) antagonist: comparison with selective OX1 and OX2 antagonists.
Malherbe P; Borroni E; Pinard E; Wettstein JG; Knoflach F
Mol Pharmacol; 2009 Sep; 76(3):618-31. PubMed ID: 19542319
[TBL] [Abstract][Full Text] [Related]
11. Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation.
Varano F; Catarzi D; Squarcialupi L; Betti M; Vincenzi F; Ravani A; Varani K; Dal Ben D; Thomas A; Volpini R; Colotta V
Eur J Med Chem; 2015; 96():105-21. PubMed ID: 25874336
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel CCR3 selective antagonist.
Naya A; Kobayashi K; Ishikawa M; Ohwaki K; Saeki T; Noguchi K; Ohtake N
Bioorg Med Chem Lett; 2001 May; 11(9):1219-23. PubMed ID: 11354381
[TBL] [Abstract][Full Text] [Related]
13. 2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists.
Scheiff AB; Yerande SG; El-Tayeb A; Li W; Inamdar GS; Vasu KK; Sudarsanam V; Müller CE
Bioorg Med Chem; 2010 Mar; 18(6):2195-2203. PubMed ID: 20188574
[TBL] [Abstract][Full Text] [Related]
14. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
Cheong SL; Dolzhenko A; Kachler S; Paoletta S; Federico S; Cacciari B; Dolzhenko A; Klotz KN; Moro S; Spalluto G; Pastorin G
J Med Chem; 2010 Apr; 53(8):3361-75. PubMed ID: 20307065
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor.
Chambers LJ; Stevens AJ; Moses AP; Michel AD; Walter DS; Davies DJ; Livermore DG; Fonfria E; Demont EH; Vimal M; Theobald PJ; Beswick PJ; Gleave RJ; Roman SA; Senger S
Bioorg Med Chem Lett; 2010 May; 20(10):3161-4. PubMed ID: 20399651
[TBL] [Abstract][Full Text] [Related]
16. Novel CGRP receptor antagonists through a design strategy of target simplification with addition of molecular flexibility.
Wood MR; Schirripa KM; Kim JJ; Quigley AG; Stump CA; Bell IM; Bednar RA; Fay JF; Bruno JG; Moore EL; Mosser SD; Roller S; Salvatore CA; Kane SA; Vacca JP; Selnick HG
Bioorg Med Chem Lett; 2009 Oct; 19(19):5787-90. PubMed ID: 19703767
[TBL] [Abstract][Full Text] [Related]
17. Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonists.
Letourneau JJ; Riviello CM; Li H; Cole AG; Ho KK; Zanetakos HA; Desai H; Zhao J; Auld DS; Napier SE; Thomson FJ; Goan KA; Morphy JR; Ohlmeyer MH; Webb ML
Bioorg Med Chem Lett; 2010 Sep; 20(18):5394-7. PubMed ID: 20719508
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel, water-soluble, 2-amino-N-pyrimidin-4-yl acetamides as A2A receptor antagonists with in vivo efficacy.
Slee DH; Zhang X; Moorjani M; Lin E; Lanier MC; Chen Y; Rueter JK; Lechner SM; Markison S; Malany S; Joswig T; Santos M; Gross RS; Williams JP; Castro-Palomino JC; Crespo MI; Prat M; Gual S; Díaz JL; Wen J; O'Brien Z; Saunders J
J Med Chem; 2008 Feb; 51(3):400-6. PubMed ID: 18189346
[TBL] [Abstract][Full Text] [Related]
19. New 2-amino-thiazole-4-acetamides with antiplatelet activity.
Rehse K; Baselt T
Arch Pharm (Weinheim); 2008 Oct; 341(10):645-54. PubMed ID: 18720337
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
